TNFRSF10A and neoplasm: As a result of the expression of the TRAIL receptors (DR4 and DR5), which are highly expressed in tumours, compared to normal cells, the efficacy of TRAIL to induce tumour regression is higher, and the toxicity effect of TRAIL on normal cells is lower, compared with other cytokines [75].